Service de médecine physique et de réadaptation, CHU Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France; Université Clermont Auvergne, 63000 Clermont-Ferrand, France; INRA, unité de nutrition humaine (UNH, UMR 1019), CRNH Auvergne, 63000 Clermont-Ferrand, France.
Service de médecine physique et de réadaptation, site du Tampon, CHU Sud Réunion, CHU Réunion, 97448 Saint-Pierre, France.
Ann Phys Rehabil Med. 2016 Jun;59(3):207-215. doi: 10.1016/j.rehab.2016.01.013. Epub 2016 Apr 11.
To assess the level of scientific evidence and the place in the rehabilitation framework of isokinetic muscle strengthening (IMS) for knee osteoarthritis (OA).
A systematic review of the English literature in MEDLINE via PubMed, the Cochrane Library, and PEDro databases for only randomized comparative trials. Data that were sufficiently homogeneous underwent comprehensive meta-analysis. Methodological assessment was done by using the CLEAR scale for non-pharmacologic trials.
We identified articles for 9 trials (696 patients). All trials were of low to moderate quality. Tolerance of IMS was considered good. Improvement in muscle strength was better with an IMS program than no treatment or an isometric exercise but did not differ with an aerobic program. We found an important effect for pain (standardized mean difference 1.218 [95% CI 0.899-1.54], P<0.001) and functional Lequesne index (1.61 [0.40-2.81], P=0.009) and a moderate effect for the Western Ontario and McMaster Universities Osteoarthritis Index subscore C for disability (0.58 [0.04-1.11], P=0.03).
IMS is an effective way to propose dynamic muscle strengthening for knee OA rehabilitation and has a significant effect on pain and disability. Because of the weak methodology and the great heterogeneity of studies, particularly in IMS protocol and outcome measures, insufficient data are available to provide guidelines about efficacy and strategy. Future clinical trials are needed, but more attention should be paid to the methods of such studies to clarify the role of IMS in the therapeutic armamentarium of knee OA.
评估等速肌肉强化(IMS)治疗膝骨关节炎(OA)的科学证据水平及其在康复框架中的地位。
通过 MEDLINE 下的 PubMed、Cochrane 图书馆和 PEDro 数据库对英文文献进行系统评价,仅纳入随机对照试验。对足够同质的数据进行综合荟萃分析。使用非药物试验的 CLEAR 量表进行方法学评估。
我们确定了 9 项试验(696 名患者)的文章。所有试验的质量均为低至中度。IMS 的耐受性被认为良好。与无治疗或等长运动相比,IMS 方案可更好地改善肌肉力量,但与有氧运动方案无差异。我们发现疼痛(标准化均数差 1.218 [95%CI 0.899-1.54],P<0.001)和功能 Lequesne 指数(1.61 [0.40-2.81],P=0.009)有重要影响,Western Ontario 和 McMaster 大学骨关节炎指数残疾亚评分 C 也有中度影响(0.58 [0.04-1.11],P=0.03)。
IMS 是一种有效的方法,可用于膝关节 OA 康复的动态肌肉强化,对疼痛和残疾有显著效果。由于研究方法学薄弱和研究的异质性较大,特别是在 IMS 方案和结局测量方面,目前尚无足够的数据提供关于疗效和策略的指南。需要进行未来的临床试验,但应更加关注这些研究的方法,以阐明 IMS 在膝关节 OA 治疗武器库中的作用。